John Joseph Reynolds

John Joseph Reynolds's AcademicInfluence.com Rankings

Biology

#10233

World Rank

#13541

Historical Rank

Cell Biology

#475

World Rank

#487

Historical Rank

Genetics

#1067

World Rank

#1166

Historical Rank

Molecular Biology

#1468

World Rank

#1495

Historical Rank

biology Degrees

Download Badge

Biology

John Joseph Reynolds's Degrees

PhD Molecular Biology Stanford University

Why Is John Joseph Reynolds Influential?

(Suggest an Edit or Addition)

(See a Problem?)

John Joseph Reynolds's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. (1987) (1223)
Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity (1985) (700)
Comparison of human stromelysin and collagenase by cloning and sequence analysis. (1986) (367)
Purification of rabbit bone inhibitor of collagenase. (1981) (306)
Binding of gelatinases A and B to type-I collagen and other matrix components. (1995) (289)
Mutations in PNKP cause microcephaly, seizures and defects in DNA repair (2010) (259)
Intermolecular Autolytic Cleavage Can Contribute to the Activation of Progelatinase A by Cell Membranes (*) (1995) (247)
The Role of Plasmhogen Activators in the Regulation of Connective Tissue Metalloproteinases a (1992) (245)
Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase. (1989) (230)
Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. (2008) (213)
Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. (1991) (206)
Evidence that latent collagenases are enzyme-inhibitor complexes. (1977) (197)
Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase. (1985) (197)
Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analysis of their actions on soluble and insoluble collagens. (1982) (196)
Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. (1998) (191)
Mouse osteoblasts synthesize collagenase in response to bone resorbing agents. (1984) (188)
Pyrophosphate stimulation of calcium uptake into cultured embryonic bones. Fine structure of matrix vesicles and their role in calcification. (1973) (180)
Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen. (1985) (175)
The origin of matrix metalloproteinases and their familial relationships (1991) (174)
Collagenase is a component of the specific granules of human neutrophil leucocytes. (1977) (174)
Mechanisms of connective tissue matrix destruction in periodontitis. (1997) (173)
Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. (1995) (168)
Origin of plasma α2HS-glycoprotein and its accumulation in bone (1976) (167)
Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components. (1983) (165)
The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. (1994) (164)
STIMULATION BY ENDOCYTOSIS OF THE SECRETION OF COLLAGENASE AND NEUTRAL PROTEINASE FROM RABBIT SYNOVIAL FIBROBLASTS (1974) (163)
Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. (1995) (162)
The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. (1983) (158)
Gingival fibroblasts degrade type I collagen films when stimulated with tumor necrosis factor and interleukin 1: evidence that breakdown is mediated by metalloproteinases. (1989) (156)
The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1. (1991) (156)
Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines. (1992) (155)
The latent collagenase and gelatinase of human polymorphonuclear neutrophil leucocytes. (1980) (153)
An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. (1981) (153)
BOD1L Is Required to Suppress Deleterious Resection of Stressed Replication Forks. (2015) (145)
Neutral metallo-proteinases of rabbit bone. Separation in latent forms of distinct enzymes that when activated degrade collagen, gelatin and proteoglycans. (1978) (136)
Advances in understanding cell interactions in tissue resorption. Relevance to the pathogenesis of periodontal diseases and a new hypothesis. (1986) (125)
Current views of collagen degeradation. Progress towards understanding the resorption of connective tissues (1985) (119)
Immunolocalization of metalloproteinases and their inhibitor in the rabbit growth plate. (1989) (118)
Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin. (1981) (116)
Gelatinase A (MMP-2) and cysteine proteinases are essential for the degradation of collagen in soft connective tissue. (1998) (115)
Inhibition of bone resrption by selctive inactivators of cysteine proteinases (1994) (111)
Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells. Characterization and use of a specific antiserum. (1985) (109)
Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase. (1995) (95)
PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination (2017) (95)
Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts. (1994) (94)
Characterization of a specific antiserum for mammalian collagenase from several species: immunolocalization of collagenase in rabbit chondrocytes and uterus. (1986) (94)
The release of interleukin‐1β, tumor necrosis factor‐α and i nterferon‐γ by cultured peripheral blood mononuclear cells from patient swith periodontitis (1990) (91)
Metalloproteinases and cancer invasion and metastasis. (1989) (89)
Metalloproteinases and tissue damage. (1991) (88)
Bacterial antigens induce collagenase and prostaglandin E2 synthesis in human gingival fibroblasts through a primary effect on circulating mononuclear cells (1987) (85)
Site-directed mutations that alter the inhibitory activity of the tissue inhibitor of metalloproteinases-1: importance of the N-terminal region between cysteine 3 and cysteine 13. (1992) (83)
Immunolocalization of matrix metalloproteinases and TIMP-1 (tissue inhibitor of metalloproteinases) in human gingival tissues from periodontitis patients. (1994) (82)
Stimulation of bone resorption in vitro by a non-prostanoid factor released by human monocytes in culture. (1983) (82)
Identification and partial characterization of an inhibitor of collagenase from rabbit bone. (1977) (81)
Binding of latent and high Mr active forms of stromelysin to collagen is mediated by the C-terminal domain. (1991) (81)
Production of collagenase and inhibitor (TIMP) by intracranial tumors and dura in vitro. (1983) (79)
Gelatinase (type IV collagenase) immunolocalization in cells and tissues: use of an antiserum to rabbit bone gelatinase that identifies high and low Mr forms. (1989) (79)
Extracellular Matrix Degradation (2003) (78)
A fibrosarcoma model derived from mouse embryo cells: Growth properties and secretion of collagenase and metalloproteinase inhibitor (TIMP) by tumour cell lines (1984) (77)
Characterization of a specific antiserum to rabbit stromelysin and demonstration of the synthesis of collagenase and stromelysin by stimulated rabbit articular chondrocytes. (1986) (77)
Effect of poly DL-lactide--co-glycolide implants and xenogeneic bone matrix-derived growth factors on calvarial bone repair in the rabbit. (1994) (75)
Rabbit bone collagenase inhibitor blocks the activity of other neutral metalloproteinases. (1979) (75)
Purification and characterization of human 72-kDa gelatinase (type IV collagenase). Use of immunolocalisation to demonstrate the non-coordinate regulation of the 72-kDa and 95-kDa gelatinases by human fibroblasts. (1991) (73)
Inhibition by calcitonin of bone resorption induced in vitro by vitamin A (1968) (72)
Histone Methylation by SETD1A Protects Nascent DNA through the Nucleosome Chaperone Activity of FANCD2 (2018) (71)
Tissue inhibitor of metalloproteinases (TIMP) regulates extracellular type I collagen degradation by chondrocytes and endothelial cells. (1987) (70)
Mutations in DONSON disrupt replication fork stability and cause microcephalic dwarfism (2017) (66)
Distribution of matrix metalloproteinases and their inhibitor, TIMP‐1, in developing human osteophytic bone (1997) (66)
The detection and characterisation of collagenase inhibitors from rabbit tissues in culture. (1977) (64)
Human gingival tissues in culture synthesize three metalloproteinases and a metalloproteinase inhibitor. (1982) (63)
Origin of plasma alpha2HS-glycoprotein and its accumulation in bone. (1976) (62)
Inhibition of stimulated bone resorption in vitro by TIMP-1 and TIMP-2. (1993) (62)
A NEW FACTOR THAT MAY CONTROL COLLAGEN RESORPTION (1977) (61)
Impact of PNKP mutations associated with microcephaly, seizures and developmental delay on enzyme activity and DNA strand break repair (2012) (61)
Defective DNA Ligation during Short-Patch Single-Strand Break Repair in Ataxia Oculomotor Apraxia 1 (2008) (58)
Type I collagen degradation by mouse calvarial osteoblasts stimulated with 1,25-dihydroxyvitamin D-3: evidence for a plasminogen-plasmin-metalloproteinase activation cascade. (1989) (58)
Metalloproteinase inhibitors from bovine cartilage and body fluids. (1984) (57)
Production of collagenase by human osteoblasts and osteoclasts in vivo. (1996) (56)
Production of collagenase and inhibitor (TIMP) by normal, rheumatoid and osteoarthritic synovium in vitro: effects of hydrocortisone and indomethacin. (1981) (55)
The effect of ascorbic acid on the growth of chick bone rudiments in chemically defined medium. (1966) (54)
Metalloproteinases are not involved in the phagocytosis of collagen fibrils by fibroblasts. (1989) (54)
Cytochalasin B increases collagenase production by cells in vitro (1975) (54)
Localisation of matrix metalloproteinases and TIMP-2 in resorbing mouse bone (2000) (53)
Stromelysin (MMP‐3) Synthesis Is Up‐Regulated in Estrogen‐Deficient Mouse Osteoblasts In Vivo and In Vitro (1999) (51)
A second plasma calcium-lowering peptide from the human calcitonin precursor (1982) (49)
Characterization of collagenase, other metallo-proteinases and an inhibitor (TIMP) produced by human synovium and cartilage in culture. (1981) (49)
Effects of products from macrophages, blood mononuclear cells and or retinol on collagenase secretion and collagen synthesis in chondrocyte culture. (1982) (49)
THE BIOSYNTHESIS OF FOLIC ACID. IV. ENZYMATIC SYNTHESIS OF DIHYDROFOLIC ACID FROM GUANINE AND RIBOSE COMPOUNDS. (1964) (46)
A sensitive in vitro method for studying the induction and inhibition of bone resorption (2005) (42)
The effect of two diphosphonates on the resorption of mouse calvariain vitro (2005) (42)
The effect of hydrocortisone on the growth of chick bone rudiments in chemically defined medium. (1966) (41)
Rabbit cranial suture fibroblasts under tension express a different collagen phenotype. (1982) (40)
Pig interleukin 1 (Catabolin) is a potent stimulator of bone resorptionin vitro (2007) (38)
Cell-mediated degradation of type IV collagen and gelatin films is dependent on the activation of matrix metalloproteinases. (1992) (38)
Zinc metalloenzyme properties of active and latent collagenase from rabbit bone. (1981) (38)
The synthesis of collagenase, gelatinase-A (72 kDa) and -B (95 kDa), and TIMP-1 and -2 by human osteoblasts from normal and arthritic bone. (1995) (37)
The effects of serine proteinase inhibitors on bone resorption in vitro. (2003) (37)
Degradation of type I collagen films by mouse osteoblasts is stimulated by 1,25 dihydroxyvitamin D3 and inhibited by human recombinant TIMP (tissue inhibitor of metalloproteinases). (1987) (35)
Expanding the ataxia with oculomotor apraxia type 4 phenotype (2016) (34)
Rabbit cranial sutures in vitro: A new experimental model for studying the response of fibrous joints to mechanical stress (1979) (34)
The use of in vitro models for investigating the response of fibrous joints to tensile mechanical stress. (1984) (33)
Effects of retinol and dexamethasone on cytokine-mediated control of metalloproteinases and their inhibitors by human articular chondrocytes and synovial cells in culture. (1983) (33)
Matrix metalloproteinases in the formation of human synovial joint cavities. (1996) (32)
Inhibition of type I collagen film degradation by tumour cells using a specific antibody to collagenase and the specific tissue inhibitor of metalloproteinases (TIMP). (1985) (32)
Bone-derived growth factors modulate collagenase and TIMP (tissue inhibitor of metalloproteinases) activity and type I collagen degradation by mouse calvarial osteoblasts. (1991) (32)
A factor synthesized by rabbit periosteal fibroblasts stimulates bone resorption and collagenase production by connective tissue cells in vitro. (1984) (31)
The role of vitamin D metabolites in bone resorption (2005) (31)
Purification and properties of a specific collagenase from rabbit synovial fibroblasts. (1975) (29)
The release of interleukin-1 beta, tumor necrosis factor-alpha and interferon-gamma by cultured peripheral blood mononuclear cells from patients with periodontitis. (1990) (28)
Rabbit models of arthritis: immunolocalization of matrix metalloproteinases and tissue inhibitor of metalloproteinase in synovium and cartilage. (1993) (28)
Bone-derived growth factor release from poly(α-hydroxy acid) implants in vitro (1993) (28)
Matrix metallproteinases and TIMP‐1 localization at sites of osteogenesis in the craniofacial region of the rabbit embryo (1995) (26)
The synthesis of collagen by chick bone rudiments in vitro. (1967) (25)
Proteoglycan-degrading enzymes of rabbit fibroblasts and granulocytes. (1978) (24)
Time Course of Action of Calcitonin on Resorbing Mouse Bones in vitro (1968) (24)
A nervous predisposition to unrepaired DNA double strand breaks. (2013) (24)
Messenger function of prostaglandins in cell to cell interactions and control of proteinase activity in the rheumatoid joint. (1982) (23)
A second plasma calcium-lowering peptide from the human calcitonin precursor—a re-evaluation (1984) (22)
Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer (2017) (21)
Stromelysin, gelatinase A and TIMP‐1 in prosthetic interface tissue: a role for macrophages in tissue remodelling (1995) (19)
Effect of tensile mechanical stress on the synthesis of metalloproteinases by rabbit coronal sutures in vitro (2006) (19)
Inhibition by diphosphonates of bone resorption in mice and comparison with grey-lethal osteopetrosis (2005) (19)
Immunolocalization of collagenase and tissue inhibitor of metalloproteinases (TIMP) in mechanically deformed fibrous joints. (1990) (19)
Tissue inhibitor of metalloproteinases and collagenase inhibitory activity in lung secretions from patients with chronic obstructive bronchitis: effect of corticosteroid treatment. (1986) (17)
Bi-allelic Variants in TONSL Cause SPONASTRIME Dysplasia and a Spectrum of Skeletal Dysplasia Phenotypes. (2019) (17)
Short-patch single-strand break repair in ataxia oculomotor apraxia-1. (2009) (16)
Bone Resorption in Vitro and its Inhibition by Calcitonin (1968) (16)
Regional and temporal changes in the synthesis of matrix metalloproteinases and TIMP-1 during development of the rabbit mandibular condyle. (1994) (16)
Immunochemical studies with a specific antiserum to rabbit fibroblast collagenase. (1975) (16)
819. Alkaloid biosynthesis. Part VI. The biosynthesis of colchicine (1964) (15)
Osteopetrotic (grey-lethal) bone produces collagenase and TIMP in organ culture: regulation by vitamin A. (1990) (15)
DONSON and FANCM associate with different replisomes distinguished by replication timing and chromatin domain (2020) (15)
Species discrimination between calcitonins. (1968) (14)
Effects of corticosteroids on cellular interactions in human joint tissues in culture (1981) (13)
The degradation of collagen in pig synovium in vitro and the effect of colchicine. (1989) (13)
Rabbit calvarial osteoblasts in culture constitutively synthesize progelatinase-A, and TIMP-1 and TIMP-2. (1994) (13)
Effect of environmental factors on the repair of bone in vitro. (1968) (13)
The functional balance of metalloproteinases and inhibitors in tissue degradation: relevance to oral pathologies. (1997) (13)
The production in culture of metalloproteinases and an inhibitor by joint tissues from normal rabbits, and from rabbits with a model arthritis (2004) (12)
Porcine collagenase from synovial fibroblasts: cDNA sequence and modulation of expression of RNA in vitro by various cytokines. (1991) (12)
The effects of razoxane (ICRF 159) on the production of collagenase and inhibitor (TIMP) by stimulated rabbit articular chondrocytes. (1983) (12)
Enzymatic formation of the pteridine moiety of folic acid from guanine compounds. (1962) (12)
A single strand that links multiple neuropathologies in human disease. (2013) (12)
Identification of matrix metalloproteinases and their inhibitor in the articular disc of the craniomandibular joint of the rabbit. (1996) (12)
RECON syndrome is a genome instability disorder caused by mutations in the DNA helicase RECQL1 (2022) (12)
Rabbit collagenase. Immunological identity of the enzymes released from cells and tissues in normal and pathological conditions. (1975) (11)
Novel PNKP mutations causing defective DNA strand break repair and PARP1 hyperactivity in MCSZ (2019) (11)
A sensitiviein vitro method for studying the induction and inhibition of bone resorption (1969) (11)
BIOGENESIS OF THE WATER-SOLUBLE VITAMINS. (1963) (11)
The effects of antirheumatic drugs on the production of collagenase and tissue inhibitor of metalloproteinases (TIMP) by stimulated rabbit articular chrondrocytes. (1984) (11)
Enzymatic formation of dihydropteroic acid from 2-amino-4-hydroxy-6-trihydroxypropyl-7, 8-dihydropteridine (1964) (11)
Properties of rheumatoid and normal synovial tissue in vitro and cells derived from them (1982) (10)
THE MOLECULAR AND CELLULAR INTERACTIONS INVOLVED IN CONNECTIVE TISSUE DESTRUCTION (1985) (10)
The structure of senegenic acid, a nortriterpene artifact from Polygala senega. (1965) (10)
Inhibitory effect of salmon and other calcitonins on calcium release from mouse bone in vitro. (1971) (10)
An inhibitor of mammalian collagenase from foetal rabbit bone in culture. (1977) (9)
The promotion and inhibition of collagen-breakdown in organ cultures of pig synovium: the requirement for serum components and the involvement of cyclic adenosine 3':5'-monophosphate (cAMP). (1986) (9)
Metalloproteinase production by rabbit articular cartilage: comparison of the effects of interleukin-1α in vitro and in vivo (2004) (8)
The production in culture of metalloproteinases and an inhibitor by joint tissues from normal rabbits, and from rabbits with a model arthritis (2004) (8)
Cytokines, matrix metalloproteinases and tissue inhibitor of metalloproteinases‐1 in gingival crevicular fluid from patients with Papillon‐Lefèvre syndrome (2004) (8)
An in vitro bioassay for 1,25-dihydroxyvitamin D3 and other antirachitic agents (1977) (8)
Analysis of novel missense ATR mutations reveals new splicing defects underlying Seckel syndrome (2018) (7)
104. Studies on specific chemical fission of peptide links. Part III. Fission of peptides containing one glutamic acid residue (1961) (7)
DIPHOSPHONATES INHIBIT PRODUCTION OF PROSTAGLANDIN AND COLLAGENASE BY HUMAN-CELLS INVITRO (1981) (7)
Immunolocalization of metalloproteinases and TIMP in normal and pathological tissues. (1992) (7)
Histone Methylation by SETD 1 A Protects Nascent DNA through the Nucleosome Chaperone Activity of FANCD 2 (2018) (6)
Comparison of the inhibition of avian and mammalian bone alkaline phosphatases by levamisole and compound R8231 (1977) (6)
Collagenase is expressed by rabbit VX2 tumour cells in syngeneic and xenogeneic hosts. (1989) (6)
Periosteal Fibroblasts Synthesize a Cytokine That Stimulates Bone Resorption and Demonstrates Interleukin-1 Activity After Partial Purification (1985) (6)
Collagenase and collagenase inhibitor levels following changes in bone resorption in vitro (2006) (6)
Degradation processes in bone and cartilage (2005) (6)
The effects of dexamethasone in vitro on the production of collagenase and inhibitor by synovial and cartilage explants from the joints of rabbits with a proliferative arthritis (2004) (6)
Collagenase activity from cultured non-gravid rabbit uterus. (1977) (5)
Evidence that species specificity and rate of collagen degradation are properties of collagen, not collagenase. (1977) (5)
Effect of streptococcal cell wall components on bone metabolism in vitro (1982) (5)
1,25-Dihydroxycholecalciferol increases bone resorption in thyroparathyroidectomised mice (1976) (5)
Senegenic acid, a pentacyclic nor-triterpene acid (1964) (4)
Model systems for studying the destruction of the extracellular matrix and their usefulness in testing inhibitors (1988) (4)
The response of mouse bones to calcitonin preparations from different species (1969) (4)
The expression of matrix metalloproteinases and their inhibitors by pig synovial cells and their regulation by combinations of cytokines and growth factors. (1993) (4)
Collagen degradation by osteoblasts (1987) (4)
Bone cell physiology and in vitro techniques in its investigation (1990) (4)
The purification and partial characterization of bone resorptive polypeptides from bovine bone matrix. (1994) (4)
1 BOD 1 L IS REQUIRED TO SUPPRESS DELETERIOUS RESECTION OF STRESSED 1 REPLICATION FORKS 2 3 (2015) (3)
The response of mouse bones to calcitonin preparations from different species (2005) (3)
Inhibition of production and action of tissue metalloproteinases. (1986) (3)
Collagenase production by an osteoblast-enriched population of bone cells from mouse calvariae: Response to various resorbing agents (1983) (2)
Mutations in DONSON disrupt replication fork stability and cause microcephalic 1 dwarfism . 2 3 (2017) (2)
Production of a Specific Collagenase by Rabbit Synovial Cells in Continuous Cell Culture (1973) (2)
The effect of parathyroid hormone and vitamin D3 metabolites on CaBP synthesis by embryonic duodenum, in vitro. (1978) (2)
The induction and inhibition of bone resorption in vitro (2005) (2)
Bone-derived growth factor release from poly(alpha-hydroxy acid) implants in vitro. (1993) (2)
Interactions in connective tissues involving monocyte/macrophages and control of production of proteinases and proteinase inhibitors. (1982) (1)
Mediators of Osteoclast Activation in vitro and their Relevance to Resorption in Periodontal Diseases (1988) (1)
Investigating the link between defective DNA end-processing and human neurological disease (2012) (1)
A new factor that may control resorption (1978) (1)
Reply: A single strand that links multiple neuropathologies in human disease. (2014) (1)
Mechanisms of Normal and Pathological Demineralization Group Report (1982) (1)
The binding of rabbit bone inhibitor of collagenase to concanavalin A--Sepharose [proceedings]. (1980) (1)
THE RELATION OF PHAGOCYTOSIS TO THE SECRETION OF NON-LYSOSOMAL ENZYMES BY CONNECTIVE TISSUE CELLS (1975) (1)
Biosynthesis of colchicine. (1960) (1)
Factors Influencing Production of Enzymes by Human Synovium in vitro1 (1982) (1)
Inhibitory effect of follicle stimulating hormone on parathormone in the mouse--a possible explanation of postmenopausal osteoporosis. (1982) (0)
O1. Selective inactivators of cysteine proteinases inhibit bone resorption (1994) (0)
P3. Matrix melalloproteinases and TIMF expression by human osteoblasts in vitro: effect of parathyroid hormone and monocyte conditioned medium (1992) (0)
P63. Synthetic matrix metalloproteinase (MMP) inhibitors prevent bone resorption in vitro (1994) (0)
Identification and Partial Characterization of an Inhibitor of Coliagenase from Rabbit Bone (2005) (0)
Expression of Collagenase and other Matrix Metalloproteinases in Human Bone in Vivo (1995) (0)
Mutations in DONSON disrupt replication fork stability and cause microcephalic dwarfism (2017) (0)
Pathogenic variants in SLF2 and SMC5 cause segmented chromosomes and mosaic variegated hyperploidy (2022) (0)
Letter to the editor (0)
Excessive transcription-replication conflicts are a vulnerability of BRCA1-mutant cancers. (2023) (0)
Oculomotor Apraxia 1 Single-Strand Break Repair in Ataxia Defective DNA Ligation during Short-Patch (2014) (0)
19. The role of osteoblasts in bone resorption (1988) (0)
P27. Rabbit osteoblasts constitutively synthesize progelatinase-A (72 kDa) and progelatinase-B (95 kDa) (1994) (0)
Bone Remodelling: in vitro Studies on Vitamin D Metabolites (2008) (0)
Multiple interactions of corticosteroids with tissues of human joints (1980) (0)
CaBP production by chick duodenumin vitro in response to vitamin D3, its metabolites and PTH (1976) (0)
The Synthesis of Collagenase, (95 kDa), and TIMP-1 and -2 Normal and Arthritic Bone Gelatinase-A (72 kDa) and -B by Human Osteoblasts From (1995) (0)
O3. In vivo and in vitro effects of 1,25-dihydroxyvitamin D3 on bone metabolism (1994) (0)
Rabbit bonesinculture produce specific collagenase andneutral metallo-proteinase activity inlatent formsthatcanbeactivated byeither 4-aminophenylmercuric (1978) (0)
Title Histone Methylation by SETD 1 A Protects Nascent DNAthrough the Nucleosome Chaperone Activity of FANCD 2 (2018) (0)
Metalloproteinases and Their Natural Inhibitors Connective Tissue Degradation in Health and Periodontal Disease and the Roles of Matrix (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With John Joseph Reynolds?

John Joseph Reynolds is affiliated with the following schools:

John Joseph Reynolds's Academic­Influence.com Rankings

John Joseph Reynolds's Degrees

Why Is John Joseph Reynolds Influential?

John Joseph Reynolds's Published Works

Published Works

What Schools Are Affiliated With John Joseph Reynolds?

John Joseph Reynolds's AcademicInfluence.com Rankings